Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Vaxelis injection, 0.5 mL vial |
Is a |
Vaxelis |
true |
Inferred relationship |
Some |
|
|
Vaxelis injection, 0.5 mL vial |
Is a |
diphtheria + tetanus + pertussis 5 component + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-OMP) vaccine, 0.5 mL vial |
true |
Inferred relationship |
Some |
|
|
Vaxelis injection, 0.5 mL vial |
Is a |
trade product unit of use |
true |
Inferred relationship |
Some |
|
|
Vaxelis injection, 0.5 mL vial |
has manufactured dose form |
injection |
true |
Inferred relationship |
Some |
|
|
Vaxelis injection, 0.5 mL vial |
has Australian BoSS |
Bordetella pertussis toxoid |
true |
Inferred relationship |
Some |
1325537051 |
|
Vaxelis injection, 0.5 mL vial |
has intended active ingredient |
Bordetella pertussis toxoid |
true |
Inferred relationship |
Some |
1325537051 |
|
Vaxelis injection, 0.5 mL vial |
has Australian BoSS |
Haemophilus influenzae type b conjugate (PRP-OMP) antigen |
true |
Inferred relationship |
Some |
46455027 |
|
Vaxelis injection, 0.5 mL vial |
has intended active ingredient |
Haemophilus influenzae type b conjugate (PRP-OMP) antigen |
true |
Inferred relationship |
Some |
46455027 |
|
Vaxelis injection, 0.5 mL vial |
has intended active ingredient |
Bordetella pertussis fimbriae type 2 and 3 antigen |
true |
Inferred relationship |
Some |
61648552 |
|
Vaxelis injection, 0.5 mL vial |
has Australian BoSS |
Bordetella pertussis fimbriae type 2 and 3 antigen |
true |
Inferred relationship |
Some |
61648552 |
|
Vaxelis injection, 0.5 mL vial |
has intended active ingredient |
tetanus toxoid |
true |
Inferred relationship |
Some |
2039129862 |
|
Vaxelis injection, 0.5 mL vial |
has Australian BoSS |
tetanus toxoid |
true |
Inferred relationship |
Some |
2039129862 |
|
Vaxelis injection, 0.5 mL vial |
has Australian BoSS |
Bordetella pertussis pertactin antigen |
true |
Inferred relationship |
Some |
1098263981 |
|
Vaxelis injection, 0.5 mL vial |
has intended active ingredient |
Bordetella pertussis pertactin antigen |
true |
Inferred relationship |
Some |
1098263981 |
|
Vaxelis injection, 0.5 mL vial |
has Australian BoSS |
hepatitis B surface antigen |
true |
Inferred relationship |
Some |
2109368775 |
|
Vaxelis injection, 0.5 mL vial |
has intended active ingredient |
hepatitis B surface antigen |
true |
Inferred relationship |
Some |
2109368775 |
|
Vaxelis injection, 0.5 mL vial |
has Australian BoSS |
Bordetella pertussis filamentous haemagglutinin antigen |
true |
Inferred relationship |
Some |
1182006459 |
|
Vaxelis injection, 0.5 mL vial |
has intended active ingredient |
Bordetella pertussis filamentous haemagglutinin antigen |
true |
Inferred relationship |
Some |
1182006459 |
|
Vaxelis injection, 0.5 mL vial |
has intended active ingredient |
poliovirus type 1 inactivated antigen |
true |
Inferred relationship |
Some |
14240042 |
|
Vaxelis injection, 0.5 mL vial |
has Australian BoSS |
poliovirus type 1 inactivated antigen |
true |
Inferred relationship |
Some |
14240042 |
|
Vaxelis injection, 0.5 mL vial |
has unit of use |
vial |
true |
Inferred relationship |
Some |
539079099 |
|
Vaxelis injection, 0.5 mL vial |
has Australian BoSS |
poliovirus type 3 inactivated antigen |
true |
Inferred relationship |
Some |
997742096 |
|
Vaxelis injection, 0.5 mL vial |
has intended active ingredient |
poliovirus type 3 inactivated antigen |
true |
Inferred relationship |
Some |
997742096 |
|
Vaxelis injection, 0.5 mL vial |
has intended active ingredient |
poliovirus type 2 inactivated antigen |
true |
Inferred relationship |
Some |
1257894935 |
|
Vaxelis injection, 0.5 mL vial |
has Australian BoSS |
poliovirus type 2 inactivated antigen |
true |
Inferred relationship |
Some |
1257894935 |
|
Vaxelis injection, 0.5 mL vial |
has Australian BoSS |
diphtheria toxoid |
true |
Inferred relationship |
Some |
2086164338 |
|
Vaxelis injection, 0.5 mL vial |
has intended active ingredient |
diphtheria toxoid |
true |
Inferred relationship |
Some |
2086164338 |
|